0.022
price down icon17.91%   -0.0048
 
loading

Viracta Therapeutics Inc Azioni (VIRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.32%
13.88
13.56 12.47 12.45 12.21
Interest Income/Expense
9.59%
0.858
0.949 0.953 0.921 0.88
Operating Income/Loss
2.32%
-13.88
-13.56 -12.47 -12.45 -12.21
Income/Loss From Continuing Operations Before Tax
33.59%
-9.141
-13.77 -12.60 -12.48 -12.21
Income/Loss From Continuing Operations After Tax
33.59%
-9.141
-13.77 -12.60 -12.48 -12.21
Net Income/Loss
33.59%
-9.141
-13.77 -12.60 -12.48 -12.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
70,188%
39.32
0.0559 38.68 38.56 38.46
Diluted Average Shares
70,188%
39.32
0.0559 38.68 38.56 38.46
Basic Earnings Per Share
34.29%
-0.23
-0.35 -0.33 -0.32 -0.32
Diluted Earnings Per Share
34.29%
-0.23
-0.35 -0.33 -0.32 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):